Deven Choksey believes PB Balaji’s financial expertise will benefit Tata Motors and JLR, citing his successful turnaround of Tata Motors. He also discusses Antfin’s stake sale in Paytm, emphasizing the need for robust back-end integration. Choksey expresses valuation concerns in the defense sector and favors niche pharma companies over pure generics.
Laurus Labs shares rally over 4% as Q1FY27 profit jumps 126% on strong CDMO growth
Laurus Labs reported a strong June-quarter performance, with net profit more than doubling and revenue rising 29% year-on-year, driven by robust growth in its CDMO